07:00 , Sep 19, 2016 |  BioCentury  |  Emerging Company Profile

Solid CARs

Long-standing doubts about whether CAR T cells would be effective against solid tumors were exacerbated last year after Novartis AG and the University of Pennsylvania reported that their CART-meso showed no complete or partial responses...
08:00 , Jan 18, 2016 |  BC Week In Review  |  Company News

Chimeric Therapeutics, Cancer Research UK, Cell Therapy Catapult, University of Birmingham cancer, gene/cell therapy news

Cancer Research UK’s Cancer Research Technology (CRT) Ltd. commercialization and development arm, the university and Cell Therapy Catapult partnered to launch newco Chimeric to develop a chimeric antigen receptor (CAR) T cell therapy targeting C-type...